Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 5 | 2020 | 325 | 1.120 |
Why?
|
| Prostatic Neoplasms | 5 | 2020 | 935 | 0.810 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 7 | 0.730 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 219 | 0.730 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 28 | 0.720 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 807 | 0.700 |
Why?
|
| Androgens | 1 | 2020 | 89 | 0.700 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 51 | 0.550 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.420 |
Why?
|
| Inflammation | 1 | 2016 | 618 | 0.400 |
Why?
|
| HIV-1 | 3 | 2022 | 706 | 0.300 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 1502 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 515 | 0.250 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 2231 | 0.240 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2021 | 20 | 0.200 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 53 | 0.200 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 126 | 0.190 |
Why?
|
| Quinolines | 1 | 2020 | 64 | 0.180 |
Why?
|
| Transferrin | 2 | 2008 | 40 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 2 | 2016 | 502 | 0.150 |
Why?
|
| Chemokine CXCL5 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Interleukin-5 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Azacitidine | 1 | 2016 | 22 | 0.140 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 67 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 32 | 0.140 |
Why?
|
| Chemokines, CC | 1 | 2016 | 51 | 0.140 |
Why?
|
| Humans | 12 | 2022 | 37093 | 0.140 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2012 | 26 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 448 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 494 | 0.120 |
Why?
|
| Male | 5 | 2020 | 20025 | 0.110 |
Why?
|
| CpG Islands | 1 | 2012 | 97 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 90 | 0.100 |
Why?
|
| Protein Phosphatase 1 | 2 | 2022 | 62 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 98 | 0.100 |
Why?
|
| Genes | 1 | 2010 | 60 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 194 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2012 | 517 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 132 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2022 | 928 | 0.080 |
Why?
|
| Prostate | 1 | 2010 | 154 | 0.080 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 26 | 0.080 |
Why?
|
| Infrared Rays | 1 | 2008 | 18 | 0.080 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 30 | 0.080 |
Why?
|
| HIV Infections | 1 | 2021 | 2303 | 0.080 |
Why?
|
| Aged | 3 | 2019 | 6741 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 78 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 218 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 181 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 1371 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2010 | 681 | 0.060 |
Why?
|
| Middle Aged | 3 | 2019 | 10129 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 481 | 0.060 |
Why?
|
| Haplotypes | 1 | 2004 | 182 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2004 | 161 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Mice | 4 | 2022 | 5913 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 16 | 0.050 |
Why?
|
| Adult | 2 | 2019 | 11712 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2021 | 37 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 45 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 197 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 110 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 234 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 301 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2022 | 578 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 278 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 674 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 972 | 0.040 |
Why?
|
| Proteins | 1 | 2020 | 369 | 0.040 |
Why?
|
| Fluorescence | 2 | 2008 | 121 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 739 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 974 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1130 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 15081 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2379 | 0.030 |
Why?
|
| Female | 1 | 2012 | 20969 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2010 | 10 | 0.020 |
Why?
|
| Osteonectin | 1 | 2010 | 7 | 0.020 |
Why?
|
| Health | 1 | 2010 | 30 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4268 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 623 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 5363 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 474 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 15 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 63 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 122 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 47 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2007 | 28 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2007 | 23 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 113 | 0.020 |
Why?
|
| Magnetics | 1 | 2007 | 36 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 116 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2010 | 384 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 337 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 118 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 259 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 104 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 358 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 286 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 997 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3562 | 0.010 |
Why?
|